Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Heart Tronics Inc. (HRTT : OTC)
 
 • Company Description   
Heart Tronics Inc, formerly Signalife Inc., is a medical device company engaged in the research, development and marketing of medical devices that monitor and measure physiological signals, intended to detect diseases that affect an individual's health. The Company is dedicated to creating the next-generation of heart monitoring technology. Heart Tronics's unique patented technology reduces distortions, allowing physicians and cardiologists to monitor ECG signals from a patient in his or her everyday environment, solving a major cardiac care problem and giving researchers access to new and relevant clinical data. The Company's initial product, the Signalife Fidelity 100 Monitor System or (Fidelity 100), is a heart monitoring system that uses Signalife's own signal acquisition technology to obtain, amplify and process physiological signals associated with a patient's cardiovascular system. The Company also has several products in the development stage that operate using the same signal acquisition technology.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.00 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 895.57
52 Week High: $0.00
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 12.62%
12 Week 0.00% 9.93%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4705 LAUREL CANYON BLVD SUITE 203
-
STUDIO CITY,CA 91607
USA
ph: 864-233-2300
fax: 818-432-4567
None http://www.hearttronics.com
 
 • General Corporate Information   
Officers
Lowell T. Harmison - President; Chief Executive Officer and Director
Kevin F. Pickard - Interim Chief Financial Officer
Jennifer Black - Director
Rowland Perkins - Director
Charles H. Harrison - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 42234M101
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 9.00 (0.00:1)
Beta: 895.57
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©